Ultragenyx Pharmaceutical Inc. (RARE) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Ultragenyx Pharmaceutical Inc. (RARE) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $2.61B, listed on NASDAQ, employing roughly 1,294 people, carrying a beta of 0.39 to the broader market. Ultragenyx Pharmaceutical Inc. Led by Emil D. Kakkis, public since 2014-01-31.
Snapshot as of May 15, 2026.
- Spot Price
- $25.07
- Total OI
- 31.7K